Is CRP a Reliable Marker of Chronic Inflammation?
Yes, C-reactive protein (CRP) is a reliable marker of chronic inflammation and is the most clinically useful inflammatory biomarker available for assessing sustained inflammatory activation in conditions like cardiovascular disease, diabetes, and other chronic inflammatory states. 1, 2
Why CRP Works for Chronic Inflammation
CRP has emerged as the preferred inflammatory marker because of its superior analytic characteristics compared to other inflammatory markers like fibrinogen and serum amyloid A (SAA). Of all inflammatory markers identified, CRP has the analyte and assay characteristics that are most conducive for clinical use 1. Key advantages include:
- Exceptional preanalytical stability in serum or plasma at room temperature or frozen for extended periods 1
- Standardized, widely available assays with high sensitivity (high-sensitivity CRP or hsCRP) that can detect concentrations down to 0.3 mg/L 1
- Reliable measurement of the low-level chronic inflammation (typically <3 mg/L) that differs from acute inflammatory responses 2
Understanding the Chronic vs. Acute Distinction
The critical insight is that CRP functions as both an acute-phase reactant and a marker of sustained inflammatory activation 2. While CRP can rise several hundredfold (above 500 mg/L) during acute illness, the concentrations relevant for chronic inflammation assessment are much lower—typically in the range of 1-10 mg/L 1, 2.
For chronic inflammation risk stratification, use these CDC/AHA-recommended categories 1:
- Low risk: <1.0 mg/L
- Average risk: 1.0-3.0 mg/L
- High risk: >3.0 mg/L
Clinical Application Guidelines
To properly assess chronic inflammation 1:
- Obtain 2 measurements (fasting or nonfasting) optimally 2 weeks apart and average the results
- If CRP >10 mg/L, repeat the test and examine the patient for sources of acute infection or inflammation
- Report results in mg/L to one decimal point
Important Caveats
The traditional 10 mg/L cutoff for excluding "acute" inflammation is problematic and may inadvertently exclude patients with chronic inflammatory conditions of clinical interest 2. This cutoff originated from a 1981 study using outdated assay methods and lacks strong scientific justification. Many chronic conditions can produce CRP values >10 mg/L, including:
- Inflammatory bowel disease 1
- Rheumatoid arthritis 1
- Chronic alcoholism 1
- Osteoporosis (mean 6.53 mg/L) 3
- Chronic bronchitis/emphysema 3
One critical limitation: CRP may be unreliable in patients with liver dysfunction, as CRP is synthesized by hepatocytes. Patients with liver disease show significantly lower CRP levels during active inflammatory disease compared to those without liver dysfunction 4.
Evidence for Chronic Disease Association
Recent evidence strongly supports CRP's role in chronic inflammation assessment. Randomized controlled trials (CANTOS, COLCOT, LoDoCo2) demonstrated that suppression of chronic inflammation reduces cardiovascular events independently of cholesterol levels 5. CRP has been validated as a marker of chronic inflammation in:
- Cardiovascular disease 5, 6, 7
- Type 2 diabetes 6, 3
- Alzheimer's and Parkinson's disease 6
- Crohn's disease (though less reliable in ulcerative colitis) 8
- Various chronic inflammatory conditions 3, 9
High-sensitivity CRP is practical, reliable, and represents the current standard for assessing low-grade chronic inflammation in clinical practice 5.